BioStock: Strengthened financial muscle for BiBBInstruments

Lund-based BiBBInstruments has developed the world’s first CE-marked electromechanical biopsy instruments for endoscopic use, which aims to improve the current diagnosis of serious and difficult-to-diagnose tumours. The directed share issue, conducted earlier this year, creates opportunities for the company to continue its development and present several clinical news in the coming year.

Read the full article about BiBBInstruments at biostock.se:

https://www.biostock.se/en/2022/05/strengthened-financial-muscle-for-bibbinstruments/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/